Alprostadil liposome microsphere preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING TIDE PHARMA
- Publication Date
- 2010-06-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention belongs to the field of pharmaceutical preparations, in particular to an alprostadil lipid microsphere preparation, in particular to an alprostadil lipid microsphere preparation containing a stabilizer. Background technique
[0002] Alprostadil (PGE 1 ), also known as prostaglandin E1, the chemical name is (1R, 2R, 3R)-3-hydroxy-2[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentyl Alkaneheptanoic acid, which belongs to natural prostaglandin (PG) analogs, is a highly active endogenous physiologically active substance, which can be synthesized in various tissue cells of the human body.
[0003] PGE 1 It has a variety of pharmacological activities: it can significantly expand peripheral and coronary vessels, improve hemodynamics and hemorheology; inhibit platelet aggregation, reduce platelet hyperreactivity and thromboxane A (TXA) levels; inhibit free Ca of vascular smooth muscle cells 2+ , Inhibit the release of norepinephrine from vascular ...